Vanessa L. Pascoe, BA; Monica Enamandram, MD; Kristen C. Corey, MD; et al.
free access
JAMA Dermatol. 2015;151(4):375-381. doi:10.1001/jamadermatol.2014.3513
This Original Investigation proposes that the Physician Global Assessment is a potentially useful tool to track acne and psoriasis outcomes over time.
Mackenzie R. Wehner, MD; Eleni Linos, MD, DrPH; Rupa Parvataneni, MS; et al.
free access
JAMA Dermatol. 2015;151(4):382-388. doi:10.1001/jamadermatol.2014.3307
This prospective observational cohort study finds that among patients with first keratinocyte carcinoma, a subset may not develop a subsequent tumor. Results were consistent for basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (SCC).
Carly A. Werner, MD; Melissa J. Papic, BS; Laura K. Ferris, MD, PhD; et al.
free access
has audio
JAMA Dermatol. 2015;151(4):389-393. doi:10.1001/jamadermatol.2014.4171
This survey study found that a contraceptive information sheet can significantly improve patients’ contraceptive knowledge and may be a useful addition to efforts to prevent isotretinoin-induced birth defects.
-
Audio Author Interview:
Education to Promote Safe Use of Isotretinoin (JAMA Dermatology)
Kevin A. Fajardo, MD, MPH, MTMH; Patrick Keller, MD, MPH; Todd Kobayashi, MD; et al.
free access
JAMA Dermatol. 2015;151(4):395-400. doi:10.1001/jamadermatol.2014.3794
This observational study rules out training-related risk factors as the sources of bilateral lower extremity inflammatory lymphedema in Air Force basic trainees.
Jonathan I. Silverberg, MD, PhD, MPH; Amy S. Paller, MD, MS
free access
has audio
JAMA Dermatol. 2015;151(4):401-409. doi:10.1001/jamadermatol.2014.3432
Data from 9 US population-based studies find that a small subset of children and adolescents with severe eczema accompanied by prominent insufficient sleep may have potentially reversible vertical growth impairment.
-
Audio Clinical Review:
Treating Pediatric Eczema
Hanna Eriksson, MD, PhD; Abdlsattar Zebary, MD, PhD; Ismini Vassilaki, MD; et al.
free access
JAMA Dermatol. 2015;151(4):410-416. doi:10.1001/jamadermatol.2014.3689
This retrospective cohort study found VE1 immunohistochemical analysis to be a useful and rapid assay for BRAFV600E mutations.